Lasa Supergenics: Certificate under SEBI (Depositories and Participants) Regulations, 2018
Lasa Supergenics Limited received a certificate for the quarter ended December 31, 2025, under SEBI (Depositories and Participants) Regulations, 2018. The certificate confirms processing of dematerialized securities and substitution in the register of members.
This is a standard regulatory compliance filing related to share dematerialization and does not involve any new business, financial results, or corporate actions that would significantly impact the company.
The announcement is a routine regulatory filing and does not contain any information that would positively or negatively impact the company's stock or business operations.
Lasa Supergenics Limited has received a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. This certificate was received from Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent.
The certificate confirms that securities received from depository participants for dematerialization up to December 31, 2025, were processed. Specifically, the dematerialized securities were confirmed (accepted/rejected) to the depositories, and the securities were listed on the stock exchange where they were previously listed. Furthermore, the security certificates received for dematerialization were mutilated and cancelled after verification by the depository participant, and the depositories were substituted as the registered owner within 15 days of receipt.
The company has requested that this information be noted on record.
What to do with a filing like this
Lasa Supergenerics Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lasa Supergenerics Limited. Read the original for the full detail.